Trials / Unknown
UnknownNCT00089687
GBR 12909 Study in Cocaine Experienced African American Volunteers - 1
GBR 12909 Study in Cocaine Experienced African American Volunteers
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (planned)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess GBR 12909 in cocaine experienced African American Volunteers.
Detailed description
Double-blind, placebo-controlled, safety and pharmacology study with 75 mg dosage of GBR 12909 in cocaine experienced African American Volunteers. Particular interest is being given to the hematological safety data.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GBR 12909 |
Timeline
- Start date
- 2004-04-01
- Completion
- 2005-05-01
- First posted
- 2004-08-11
- Last updated
- 2017-01-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00089687. Inclusion in this directory is not an endorsement.